[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349272-105":59,"doc-detail-349272-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","burden-and-temporal-trends-of-female-specific-cancers-in-china-a-systematic-analysis-of-the-2023-global-burden-of-disease-study","Burden and temporal trends of female-specific cancers in China - A systematic analysis of the 2023 global burden of disease study","","Female-specific cancers pose a major public health challenge in China. Using incidence, mortality, and DALYs data from the Global Burden of Disease (GBD) 2023 study, this research evaluates temporal trends from 1990–2023 for breast, cervical, uterine, and ovarian cancers. Joinpoint analysis estimates trend changes, while decomposition and a Bayesian age-period-cohort (BAPC) model attribute drivers and project burden trends over the next 15 years. Results show declining age-standardized rates overall except breast cancer incidence, while absolute burden rises, driven mainly by population growth and aging.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/burden-and-temporal-trends-of-female-specific-cancers-in-china-a-systematic-analysis-of-the-2023-global-burden-of-disease-study/349272/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/burden-and-temporal-trends-of-female-specific-cancers-in-china-a-systematic-analysis-of-the-2023-global-burden-of-disease-study/349272.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What female-specific cancers are analyzed in this study?","Question",{"text":112,"@type":113},"The analysis covers breast, cervical, uterine, and ovarian cancers among women in China.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data source is used to quantify incidence, mortality, and DALYs?",{"text":117,"@type":113},"Incidence, mortality, and disability-adjusted life-years (DALYs) are extracted from the Global Burden of Disease (GBD) 2023 database.",{"name":119,"@type":110,"acceptedAnswer":120},"What main factors are identified as contributing to changes in disease burden?",{"text":121,"@type":113},"Population growth and population aging are identified as the primary contributing factors, and the BAPC model projects continued increases in absolute burden.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349272,1790668296,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","OPEN ACCESS  \nCitation: Chen S, Yang X, Jiang S, Lin Y, Huang L, Chen H, et al. (2026) Burden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study. PLoS One 21(6): e0351539 .  \n[https://doi.org/10.1371/journal.pone.0351539](https://doi.org/10.1371/journal.pone.0351539)  \nEditor: Masoud Rahmati, Lorestan University, IRAN, ISLAMIC REPUBLIC OF  \nReceived: February 13, 2026  \nAccepted: May 28, 2026  \nPublished: June 10, 2026  \nCopyright: © 2026 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: The data utilized in this study can be accessed through the online platform of the Institute for Health Metrics and Evaluation (IHME), which can be found at [https://vizhub.healthdata.org/](https://vizhub.healthdata.org/)[ ](https://vizhub.healthdata.org/)[gbd-results/](gbd-results/.)[.](gbd-results/.)  \nRESEARCH ARTICLE  \nBurden and temporal trends of female-specific cancers in China: A systematic analysis of the 2023 global burden of disease study  \nShaoxing Chen1☯, Xiaohuang Yang2☯, Shaona Jiang1☯, Yina Lin1, Leijuan Huang1, Huiqin Chen1, Jinzhu Zheng3, Yuanfu Xie1*, Zhixing Kuang4*  \n1 Department of Radiation Oncology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China, 2 Department of Gastroenterology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China, 3 Department of Health Management Center, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, China, 4 Department of Radiotherapy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China  \n☯ These authors contributed equally to this work.  \n* [zhixingkuang@gmail.com](zhixingkuang@gmail.com) (ZK); [yuanfuxie@126.com](yuanfuxie@126.com) (YX)  \nAbstract  \nBackground  \nFemale-specific cancers represent a substantial public health challenge in China. This study was designed to evaluate temporal trends and generate future projections of the burden associated with female-specific cancers in China from 1990 to 2023.  \nMethods  \nData on incidence, mortality, and disability-adjusted life-years (DALYs) attributable to breast, cervical, uterine, and ovarian cancers among women in China were extracted from the Global Burden of Disease (GBD) 2023 database. Joinpoint analysis was used to assess temporal trends, whereas decomposition analysis was applied to quantify the contributions of epidemiological changes, population growth, and ageing to changes in disease burden; a Bayesian age-period-cohort (BAPC) model was further used to project trends in disease burden over the next 15 years.  \nResults  \nBetween 1990 and 2023, all age-standardized rates (ASRs) of female-specific cancers in China declined except for the age-standardized incidence rate (ASIR) of breast cancer, which increased from 24.54 (95% uncertainty interval [UI]: 19.7–30.79) per 100,000 in 1990 to 31.62 (95% UI: 25.4–38.22) per 100,000 in 2023. The absolute disease burden increased, with 342,725 (95% UI: 270,872–413,171) new breast cancer cases in 2023, representing a 187.24% increase. In contrast, the numbers of new cases of cervical, uterine, and ovarian cancers were 124,686 (95% UI: 77,638– 165,722), 74,990 (95% UI: 53,630–119,885), and 38,969 (95% UI: 31,914–46,805),  \nPLOS One | [https://doi.org/10.1371/journal.pone.0351539](https://doi.org/10.1371/journal.pone.0351539) June 10, 2026 1 / 19  \nFunding: The author(s) received no specific funding for this work.  \nCompeting interests: The authors have declared that no competing interests exist.  \nrespectively, with corresponding increases of 43 .63%, 82.97%, and 61.76% . Population aging and growth were the main contributing factors, and the BAPC model projected that the absolute disease burden ","cbCaihzMn32PojJb","https://ap.wps.com/l/cbCaihzMn32PojJb","pdf",2357493,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What female-specific cancers are analyzed in this study?\",\"answer\":\"The analysis covers breast, cervical, uterine, and ovarian cancers among women in China.\"},{\"question\":\"Which data source is used to quantify incidence, mortality, and DALYs?\",\"answer\":\"Incidence, mortality, and disability-adjusted life-years (DALYs) are extracted from the Global Burden of Disease (GBD) 2023 database.\"},{\"question\":\"What main factors are identified as contributing to changes in disease burden?\",\"answer\":\"Population growth and population aging are identified as the primary contributing factors, and the BAPC model projects continued increases in absolute burden.\"}]","Burden and temporal trends of female-specific cancers in China - A systematic analysis of the 2023 global burden of disease study | PDF",1790082543,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37b700fd5110ea545ab92673bb6a1081.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f1cba5982561cc1fbd6277686250d6a.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c4603e25037b8c3377fcc50419ae9a9.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1141692afea8c4b8993f386eac9b7bee.webp",980,1268]